Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             43 results found
no title author magazine year volume issue page(s) type
1 An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay Levy, Roger Abramino
 2004
 114 5-6 p. 573-577
5 p.
 article
2 Antibody-mediated interference with annexins in the antiphospholipid syndrome Rand, Jacob H.
 2004
 114 5-6 p. 383-389
7 p.
 article
3 Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome Crowther, Mark A.
 2004
 114 5-6 p. 443-446
4 p.
 article
4 Anti-β2-glycoprotein I antibodies—When and how should they be measured? Reber, Guido
 2004
 114 5-6 p. 527-531
5 p.
 article
5 Antiphospholipid antibodies and fetal compromise Branch, D. Ware
 2004
 114 5-6 p. 415-418
4 p.
 article
6 Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk? Galli, Monica
 2004
 114 5-6 p. 597-601
5 p.
 article
7 Anti-phospholipid antibodies (aPL) and apoptosis: prothrombin-dependent aPL as a paradigm for phospholipid-dependent interactions with apoptotic cells Rauch, Joyce
 2004
 114 5-6 p. 371-382
12 p.
 article
8 Antiprothrombin antibodies—are they worth assaying? Atsumi, Tatsuya
 2004
 114 5-6 p. 533-538
6 p.
 article
9 Author Index - Vols. 113-114 2004
 114 5-6 p. 677-684
8 p.
 article
10 B cell biology, apoptosis, and autoantibodies to phospholipids Cook, Matthew C.
 2004
 114 5-6 p. 307-319
13 p.
 article
11 Beta 2 glycoprotein I-function in health and disease Miyakis, Spiros
 2004
 114 5-6 p. 335-346
12 p.
 article
12 Consensus guidelines for anticardiolipin antibody testing Wong, Richard C.W.
 2004
 114 5-6 p. 559-571
13 p.
 article
13 Controversies in the antiphospholipid syndrome and stroke Gatenby, Paul A.
 2004
 114 5-6 p. 483-488
6 p.
 article
14 Coronary and valvular syndromes and antiphospholipid antibodies Cervera, Ricard
 2004
 114 5-6 p. 501-507
7 p.
 article
15 Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant Exner, Thomas
 2004
 114 5-6 p. 547-552
6 p.
 article
16 Editorial Board 2004
 114 5-6 p. IBC-
1 p.
 article
17 β2-Glycoprotein I and LDL-receptor family members de Groot, Philip G.
 2004
 114 5-6 p. 455-459
5 p.
 article
18 β2-glycoprotein I, anti-β2-glycoprotein I, and fibrinolysis Yasuda, Shinsuke
 2004
 114 5-6 p. 461-465
5 p.
 article
19 β2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity Kuwana, Masataka
 2004
 114 5-6 p. 347-355
9 p.
 article
20 Growth and function of the normal human placenta Gude, Neil M.
 2004
 114 5-6 p. 397-407
11 p.
 article
21 Haemostatic changes in pregnancy Brenner, Benjamin
 2004
 114 5-6 p. 409-414
6 p.
 article
22 How much warfarin is enough in APS related thrombosis? Erkan, Doruk
 2004
 114 5-6 p. 435-442
8 p.
 article
23 ICAA Abstracts 2004
 114 5-6 p. 603-675
73 p.
 article
24 Immunologic manipulation for the threatened fetus Benson, Elizabeth M.
 2004
 114 5-6 p. 427-434
8 p.
 article
25 Inflammatory response and the endothelium Meroni, P.L.
 2004
 114 5-6 p. 329-334
6 p.
 article
26 Instructions to Authors 2004
 114 5-6 p. I-III
nvt p.
 article
27 Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies Pierangeli, Silvia S.
 2004
 114 5-6 p. 467-476
10 p.
 article
28 Keyword Index - Vols. 113-114 2004
 114 5-6 p. 685-688
4 p.
 article
29 Libman–Sacks endocarditis associated with antiphospholipid syndrome and infection Blank, M.
 2004
 114 5-6 p. 589-592
4 p.
 article
30 Management of the neurological manifestations of APS—what do the trials tell us? Brey, Robin L.
 2004
 114 5-6 p. 489-499
11 p.
 article
31 Mechanisms of autoantibody-induced monocyte tissue factor expression Wolberg, Alisa S.
 2004
 114 5-6 p. 391-396
6 p.
 article
32 Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies Tincani, Angela
 2004
 114 5-6 p. 553-558
6 p.
 article
33 Peripheral vascular disease in antiphospholipid syndrome Vlachoyiannopoulos, Panayiotis G.
 2004
 114 5-6 p. 509-519
11 p.
 article
34 Phenotyping the haemostatic system by thrombography—potential for the estimation of thrombotic risk Regnault, Véronique
 2004
 114 5-6 p. 539-545
7 p.
 article
35 Platelet physiology and thrombosis Andrews, Robert K.
 2004
 114 5-6 p. 447-453
7 p.
 article
36 Primary, Secondary, Catastrophic Antiphospholipid Syndrome: is there a difference? Harris, E. Nigel
 2004
 114 5-6 p. 357-361
5 p.
 article
37 Tests for lupus anticoagulant revisited Derksen, Ronald H.W.M.
 2004
 114 5-6 p. 521-526
6 p.
 article
38 The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases Youinou, Pierre
 2004
 114 5-6 p. 363-369
7 p.
 article
39 The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation–reduction reactions McIntyre, John A.
 2004
 114 5-6 p. 579-587
9 p.
 article
40 The impact of the inflammatory response on coagulation Esmon, Charles T.
 2004
 114 5-6 p. 321-327
7 p.
 article
41 The interface of multiple sclerosis and antiphospholipid antibodies Chapman, Joab
 2004
 114 5-6 p. 477-481
5 p.
 article
42 The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort Petri, Michelle
 2004
 114 5-6 p. 593-595
3 p.
 article
43 Treatment of antiphospholipid syndrome in pregnancy—a systematic review of randomized therapeutic trials Lassere, Marissa
 2004
 114 5-6 p. 419-426
8 p.
 article
                             43 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands